FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022809789> ?p ?o ?g. }

• W2022809789 abstract "With increasing age neuromuscular deficits (e.g., sarcopenia) may result in impaired physical performance and an increased risk for falls. Prominent intrinsic fall-risk factors are age-related decreases in balance and strength / power performance as well as cognitive decline. Additional studies are needed to develop specifically tailored exercise programs for older adults that can easily be implemented into clinical practice. Thus, the objective of the present trial is to assess the effects of a fall prevention program that was developed by an interdisciplinary expert panel on measures of balance, strength / power, body composition, cognition, psychosocial well-being, and falls self-efficacy in healthy older adults. Additionally, the time-related effects of detraining are tested. Healthy old people (n = 54) between the age of 65 to 80 years will participate in this trial. The testing protocol comprises tests for the assessment of static / dynamic steady-state balance (i.e., Sharpened Romberg Test, instrumented gait analysis), proactive balance (i.e., Functional Reach Test; Timed Up and Go Test), reactive balance (i.e., perturbation test during bipedal stance; Push and Release Test), strength (i.e., hand grip strength test; Chair Stand Test), and power (i.e., Stair Climb Power Test; countermovement jump). Further, body composition will be analysed using a bioelectrical impedance analysis system. In addition, questionnaires for the assessment of psychosocial (i.e., World Health Organisation Quality of Life Assessment-Bref), cognitive (i.e., Mini Mental State Examination), and fall risk determinants (i.e., Fall Efficacy Scale – International) will be included in the study protocol. Participants will be randomized into two intervention groups or the control / waiting group. After baseline measures, participants in the intervention groups will conduct a 12-week balance and strength / power exercise intervention 3 times per week, with each training session lasting 30 min. (actual training time). One intervention group will complete an extensive supervised training program, while the other intervention group will complete a short version ('3 times 3’) that is home-based and controlled by weekly phone calls. Post-tests will be conducted right after the intervention period. Additionally, detraining effects will be measured 12 weeks after program cessation. The control group / waiting group will not participate in any specific intervention during the experimental period, but will receive the extensive supervised program after the experimental period. It is expected that particularly the supervised combination of balance and strength / power training will improve performance in variables of balance, strength / power, body composition, cognitive function, psychosocial well-being, and falls self-efficacy of older adults. In addition, information regarding fall risk assessment, dose–response-relations, detraining effects, and supervision of training will be provided. Further, training-induced health-relevant changes, such as improved performance in activities of daily living, cognitive function, and quality of life, as well as a reduced risk for falls may help to lower costs in the health care system. Finally, practitioners, therapists, and instructors will be provided with a scientifically evaluated feasible, safe, and easy-to-administer exercise program for fall prevention. ClinicalTrials.gov Identifier: NCT01906034" @default.
• W2022809789 created "2016-06-24" @default.
• W2022809789 creator A5012064746 @default.
• W2022809789 creator A5071369378 @default.
• W2022809789 creator A5072618575 @default.
• W2022809789 creator A5073570972 @default.
• W2022809789 creator A5079675791 @default.
• W2022809789 creator A5083984924 @default.
• W2022809789 date "2013-10-09" @default.
• W2022809789 modified "2023-10-05" @default.
• W2022809789 title "A best practice fall prevention exercise program to improve balance, strength / power, and psychosocial health in older adults: study protocol for a randomized controlled trial" @default.
• W2022809789 cites W102653936 @default.
• W2022809789 cites W120288851 @default.
• W2022809789 cites W1483541406 @default.
• W2022809789 cites W1544164856 @default.
• W2022809789 cites W1718991304 @default.
• W2022809789 cites W1770682928 @default.
• W2022809789 cites W1832525233 @default.
• W2022809789 cites W1847168837 @default.
• W2022809789 cites W1966804325 @default.
• W2022809789 cites W1974704788 @default.
• W2022809789 cites W1976472632 @default.
• W2022809789 cites W1977551001 @default.
• W2022809789 cites W1988946926 @default.
• W2022809789 cites W1989610135 @default.
• W2022809789 cites W1993053126 @default.
• W2022809789 cites W2002850170 @default.
• W2022809789 cites W2006711104 @default.
• W2022809789 cites W2008189795 @default.
• W2022809789 cites W2011295254 @default.
• W2022809789 cites W2011411081 @default.
• W2022809789 cites W2012710388 @default.
• W2022809789 cites W2016224169 @default.
• W2022809789 cites W2017341739 @default.
• W2022809789 cites W2017405761 @default.
• W2022809789 cites W2020046787 @default.
• W2022809789 cites W2025938335 @default.
• W2022809789 cites W2028502215 @default.
• W2022809789 cites W2030594499 @default.
• W2022809789 cites W2035647453 @default.
• W2022809789 cites W2036269127 @default.
• W2022809789 cites W2037557484 @default.
• W2022809789 cites W2038355611 @default.
• W2022809789 cites W2039376085 @default.
• W2022809789 cites W2043051317 @default.
• W2022809789 cites W2043365814 @default.
• W2022809789 cites W2046296871 @default.
• W2022809789 cites W2053854072 @default.
• W2022809789 cites W2053983275 @default.
• W2022809789 cites W2055707730 @default.
• W2022809789 cites W2056390667 @default.
• W2022809789 cites W2062228543 @default.
• W2022809789 cites W2068050118 @default.
• W2022809789 cites W2068248377 @default.
• W2022809789 cites W2071872965 @default.
• W2022809789 cites W2074010162 @default.
• W2022809789 cites W2078611351 @default.
• W2022809789 cites W2085127536 @default.
• W2022809789 cites W2087032312 @default.
• W2022809789 cites W2087484885 @default.
• W2022809789 cites W2097821660 @default.
• W2022809789 cites W2098832237 @default.
• W2022809789 cites W2098886451 @default.
• W2022809789 cites W2099044199 @default.
• W2022809789 cites W2100959123 @default.
• W2022809789 cites W2102902846 @default.
• W2022809789 cites W2103252230 @default.
• W2022809789 cites W2104106112 @default.
• W2022809789 cites W2107710263 @default.
• W2022809789 cites W2109025609 @default.
• W2022809789 cites W2109983425 @default.
• W2022809789 cites W2111687617 @default.
• W2022809789 cites W2112551647 @default.
• W2022809789 cites W2114420198 @default.
• W2022809789 cites W2114808153 @default.
• W2022809789 cites W2116132542 @default.
• W2022809789 cites W2117837066 @default.
• W2022809789 cites W2117925202 @default.
• W2022809789 cites W2119807233 @default.
• W2022809789 cites W2120519520 @default.
• W2022809789 cites W2122190417 @default.
• W2022809789 cites W2125811559 @default.
• W2022809789 cites W2130579318 @default.
• W2022809789 cites W2134009614 @default.
• W2022809789 cites W2135163430 @default.
• W2022809789 cites W2141228563 @default.
• W2022809789 cites W2150037517 @default.
• W2022809789 cites W2157181624 @default.
• W2022809789 cites W2158411337 @default.
• W2022809789 cites W2166232227 @default.
• W2022809789 cites W2170704717 @default.
• W2022809789 cites W2312456083 @default.
• W2022809789 cites W2314111539 @default.
• W2022809789 cites W2327239165 @default.
• W2022809789 cites W2404982666 @default.
• W2022809789 cites W4241299311 @default.
• W2022809789 cites W4252099518 @default.
• W2022809789 doi "https://doi.org/10.1186/1471-2318-13-105" @default.
• W2022809789 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3852637" @default.
• W2022809789 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24106864" @default.

• next